Microbiome for early cancer prediction before the onset of disease
Nu open voor aanvraagWaar het om gaat
Dit onderwerp richt zich op de ontwikkeling van microbioom-tools voor vroege kankerpredictie en preventie, zonder specifieke bedrijfsgrootte- of fasebeperkingen.
Samenvatting
Microbiome for early cancer prediction before the onset of disease
Vergelijkbare regelingen
Dichtstbij qua inhoud — ook over de taalgrens (RVO ↔ EU-calls), via embeddings.
- Development of predictive biomarkers of disease progression and treatment response by using AI methodologies for chronic non-communicable diseases · EU · 91% · open
- Phase 1 including first-in-human clinical trials to test biomarker-guided medicines or multi-modal treatment interventions for patients with rare or very rare cancers or cancer subtypes · EU · 90% · open
- Decode the Immunoscience of age-related diseases · EU · 90% · open
- Improve the Quality of Life of older cancer patients · EU · 90% · open
- Pre-commercial procurement of affordable solutions for healthcare systems in the areas of cancer technologies, cancer medical devices, or cancer medicines · EU · 89% · open
- Earlier and more precise palliative care · EU · 89% · open